RxDoctor Payments Data

Aaron Adams

Nurse Practitioner · Ogden, UTNPI 1972972883

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Medtronic at 40.7% of the total. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,068in general payments, 2019–2025

Across 184 payments — averaging $65.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Atricure, Inc.$3K
  • Abbott$2K
  • Boston Scientific$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$233
  • Pfizer$30
  • plus $28 from 2 others

What the payments were for

  • Travel & lodging$5,71647%
  • Food & beverage$6,35253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,068 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$53,277
Medicare patients
388
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban531$621,576
XareltoRivaroxaban201$247,347
Flecainide Acetate191$7,965
Dofetilide26$5,930
Metoprolol Succinate332$5,630
Diltiazem 24hr Er (Cd)Diltiazem Hcl131$5,123
Amiodarone Hcl127$1,707
SotalolSotalol Hcl16$568
Dilt-XrDiltiazem Hcl18$472
Metoprolol Tartrate32$452
Cartia XtDiltiazem Hcl11$291
Carvedilol25$232
Lisinopril23$225
Amlodipine Besylate12$111
Spironolactone23$91

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$30$621,576531 claims
Johnson & JohnsonXarelto$15$247,347201 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →